Phillip Broadwith
Business editor, Chemistry World
As Business editor, my aim is to highlight to readers the exciting and innovative chemistry going on in the commercial sector, as well as keeping you abreast of trends and developments in the world of chemistry businesses.
From the point I left school, my aim was to join the pharmaceutical industry. A gap year and summer placements in company labs, and a PhD in organic synthesis followed.
But halfway through my PhD I entered a writing competition run by the Daily Telegraph. I managed to win – somewhat to my own surprise. That changed my perspective and made me think that I should consider writing more seriously as a career. I joined the Royal Society of Chemistry just before submitting my thesis, and luckily a position with Chemistry World came up a few months later. I sometimes miss the thrills (less so the spills) of lab work, but interacting with world-leading scientists and industrialists, as well as learning new things on a daily basis more than makes up for it.
OpinionResistant to change
Curbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
OpinionWho knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
BusinessRecycling plastic with enzymes
Carbios can return even hard-to-recycle polyester fibres and textiles to their constituent monomers
ResearchAromatic molecules in a galaxy far, far away
JWST IR observations suggest star formation was rapid and uneven in early galaxy
BusinessDeadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
BusinessFive dead after explosion at plant in China
Blast in hydrogen peroxide unit of Sinochem plant in Liaocheng
OpinionBattery materials going up in smoke
We cannot afford to simply throw away, rather than recycle, these valuable resources
BusinessMerck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
BusinessGhana and Nigeria approve Oxford malaria vaccine
Approval comes before final-stage clinical trials have been completed
OpinionHolding the keys to a powerful future
Competition to build battery supply chains means supercharging support to attract investment
BusinessFragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities
BusinessFatal explosion and fire at chemical plant in China
Five dead, a further eight missing, and 30 more injured at Panjin Haoye Chemical
BusinessAt least 38 killed in industrial fire in China
Sparks from welding work appear to have ignited textiles at the plant
OpinionElizabeth Holmes to be imprisoned for Theranos fraud
Blood testing company founder’s 11-year sentence should serve as a warning to investors
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
BusinessRocket-powered carbon dioxide conversion
Barton Blakeley is lowering the carbon footprint of silica and other materials
BusinessJ&J to phase out talc-based baby powder worldwide
In the face of thousands of lawsuits, firm will switch to cornstarch-based formulations
BusinessAt least 13 dead in massive chlorine release in Jordan
Tanker of gas fell during loading at the port of Aqaba, injuring hundreds